Harrow (HROW) Asset Writedowns and Impairment (2016 - 2026)
Harrow (HROW) recorded quarterly Asset Writedowns and Impairment of -$195000.0 in Q1 2026, down 143.75% quarter-over-quarter from -$80000.0 in Q4 2025, and down 271.05% on a YoY basis from $114000.0 in Q1 2025.
Harrow (HROW) Asset Writedowns and Impairment (2016 - 2026) Analysis & Trends
Harrow's Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at -$195000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 271.05% year-over-year to -$195000.0; the TTM figure through Mar 2026 stood at $159000.0 (down 50.16% YoY), while the FY2025 annual figure was $468000.0, up 290.0% from the prior year.
- Asset Writedowns and Impairment was -$195000.0 for Q1 2026 at Harrow, down from -$80000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $264000.0 in Q4 2023 to a low of -$195000.0 in Q1 2026.
- Historically, Asset Writedowns and Impairment has averaged $47411.8 across 5 years, with a median of $20000.0 in 2023.
- The sharpest annual moves came in 2022 and 2024: Asset Writedowns and Impairment soared 4600.0% in 2022, then slumped 525.0% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $45000.0 in 2022, then soared by 486.67% to $264000.0 in 2023, then sank by 46.97% to $140000.0 in 2024, then tumbled by 157.14% to -$80000.0 in 2025, then plunged by 143.75% to -$195000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at -$195000.0 (Q1 2026), -$80000.0 (Q4 2025), and $208000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -195,000.00 |
| Mar 31, 2026 | -195,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Sep 30, 2025 | 208,000.00 |
| Sep 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -85,000.00 |
| Mar 31, 2024 | -85,000.00 |
| Dec 31, 2023 | 264,000.00 |
| Dec 31, 2023 | 264,000.00 |